enVVeno Medical (NVNO) Shares Outstanding (2017 - 2026)

enVVeno Medical has reported Shares Outstanding for 10 years, with the latest figure at $656000.0 in Q1 2026.

• For the quarter ending Q1 2026, Shares Outstanding rose 30.94% year-over-year to $656000.0; the trailing twelve-month figure through Mar 2026 stood at $656000.0 (up 30.94% YoY), and the FY2025 full-year result was $656000.0, up 30.94% from the prior year.
• Shares Outstanding for Q1 2026 stood at $656000.0, roughly flat from $656000.0 in the prior quarter.
• The five-year high for Shares Outstanding was $20.2 million in Q3 2025, with the low at $381000.0 in Q4 2023.
• Average Shares Outstanding over 5 years is $9.0 million, with a median of $9.5 million recorded in 2022.
• Year-over-year, Shares Outstanding soared 85.14% in 2024 and sank 96.24% in 2025.
• Tracing NVNO's Shares Outstanding over 5 years: stood at $9.5 million in 2022, then sank by 95.98% to $381000.0 in 2023, then jumped by 31.5% to $501000.0 in 2024, then surged by 30.94% to $656000.0 in 2025, then changed by 0.0% to $656000.0 in 2026.
• The last three Shares Outstanding figures came in at $656000.0 (Q1 2026), $656000.0 (Q4 2025), and $20.2 million (Q3 2025), per Business Quant data.

Peer Comparison